Clinical trial
"Progranulin in Ankylosing Spondylitis Patients: A Potential Biomarker?"
NCT07117344 is registered in ClinicalTrials.gov with Kirsehir Ahi Evran Universitesi as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- "Progranulin in Ankylosing Spondylitis Patients: A Potential Biomarker?"
- Lead sponsor
- Kirsehir Ahi Evran Universitesi
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- January 15, 2026
- Completion date
- August 30, 2026
- Enrollment
- 160 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
ankylosing spondylitis (as) / radiographic axial spa (r-axspa)